Fmr LLC Ptc Therapeutics, Inc. Transaction History

Fmr LLC

$1.81 Trillion
Q3 2025

A detailed history of Fmr LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 1,611,775 shares of PTCT stock, worth $121 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,611,775

Previous 1,718,287 6.2%

Holding current value

$121 Million

Previous $83.9 Million 17.87%

% of portfolio

0.01%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$43.3 - $62.88 $4.61 Million - $6.7 Million	-106,512 Reduced 6.2%	1,611,775 $98.9 Million
Q2 2025 Aug 14, 2025	SELL	$36.19 - $52.13 $10.7 Million - $15.4 Million	-295,275 Reduced 14.66%	1,718,287 $83.9 Million
Q1 2025 May 12, 2025	BUY	$41.81 - $57.17 $49.9 Million - $68.2 Million	1,193,518 Added 145.54%	2,013,562 $103 Million
Q4 2024 Feb 13, 2025	SELL	$34.99 - $52.07 $8.3 Million - $12.3 Million	-237,138 Reduced 22.43%	820,044 $37 Million
Q3 2024 Nov 13, 2024	SELL	$30.39 - $37.66 $1.43 Million - $1.77 Million	-46,917 Reduced 4.25%	1,057,182 $39.2 Million

Q2 2024 Aug 13, 2024	SELL	$24.69 - $40.12 $15.4 Million - $25 Million	-622,963 Reduced 36.07%	1,104,099 $33.8 Million
Q1 2024 May 13, 2024	SELL	$24.15 - $31.95 $2.11 Million - $2.79 Million	-87,359 Reduced 4.81%	1,727,062 $50.2 Million
Q4 2023 Feb 13, 2024	SELL	$18.07 - $29.37 $120 Million - $195 Million	-6,650,963 Reduced 78.57%	1,814,421 $50 Million
Q3 2023 Nov 13, 2023	SELL	$22.41 - $41.99 $40.1 Million - $75.1 Million	-1,787,740 Reduced 17.44%	8,465,384 $190 Million
Q2 2023 Aug 11, 2023	BUY	$40.4 - $59.1 $27.1 Million - $39.6 Million	669,956 Added 6.99%	10,253,124 $417 Million
Q1 2023 May 11, 2023	SELL	$38.16 - $48.86 $45.8 Million - $58.6 Million	-1,199,138 Reduced 11.12%	9,583,168 $464 Million
Q4 2022 Feb 13, 2023	BUY	$33.53 - $54.79 $1.72 Million - $2.8 Million	51,162 Added 0.48%	10,782,306 $412 Million
Q3 2022 Nov 10, 2022	BUY	$41.85 - $53.85 $1.27 Million - $1.63 Million	30,307 Added 0.28%	10,731,144 $539 Million
Q2 2022 Aug 12, 2022	SELL	$25.6 - $45.23 $673,484 - $1.19 Million	-26,308 Reduced 0.25%	10,700,837 $429 Million
Q1 2022 May 13, 2022	BUY	$33.33 - $44.6 $4.08 Million - $5.46 Million	122,460 Added 1.15%	10,727,145 $400 Million
Q4 2021 Feb 14, 2022	BUY	$35.36 - $41.86 $493,413 - $584,114	13,954 Added 0.13%	10,604,685 $422 Million
Q3 2021 Nov 15, 2021	BUY	$37.01 - $44.74 $826,988 - $999,715	22,345 Added 0.21%	10,590,731 $394 Million
Q2 2021 Aug 13, 2021	BUY	$37.95 - $49.37 $401 Million - $522 Million	10,568,386 New	10,568,386 $447 Million

Others Institutions Holding PTCT

# of Institutions

325

Shares Held

83.2M

Call Options Held

811K

Put Options Held

207K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $5.39B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account